Aton SA operates as a biopharmaceutical company, which engages in the research and development of targets and therapies for the treatment of proliferative diseases. It offers monoclonal antibodies, laboratory equipment, medical device production, human tissue provision, preclinical and clinical services. The company was founded by Arthur Donny Strosberg on December 29, 1997 and is headquartered in Paris, France.